Akebia Therapeutics, Inc.

AKBA·NasdaqCM·Healthcare
Compare
0.6947−0.0311 (−4.28%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.7258
Open0.7500
Day range0.66000.7534
52-week range0.54202.1300
Off day high−7.79%
Off 52-week high−67.38%
Volume10.83M
Avg. volume (3M)7.93M
Market cap192.51M
EPS (TTM)-0.1200
Forward P/E-1.93
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.23
Shares outstanding277.11M
Short interest8.45% of float
Earnings dateNov 5, 2026
Analyst target3.9167
Profit margin−13.54%

Against its peers

Compare in full ›
AKBA 42C.SI BCRX GUD.TO 002038.SZ 9989.HK
Market cap 192.51M 515.12M 2.11B 1.11B 5.37B 5.99B
P/E (TTM) — — — 75.3 — 27.2
Forward P/E -1.9 247.4 10.0 43.5 — 8.0
Price/book 7.6 33.6 -14.7 1.4 1.1 0.4
Dividend yield — — — — 0.19% 4.12%
1-year change −65.75% +259.26% +17.21% +86.16% −31.88% −26.10%
Today −4.28% −3.09% −3.85% +0.36% +1.55% +1.12%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MA 261.64B 706.16 +1.12%
Veralto CorporationVLTO · Waltham, MA 28.45B 117.02 +0.60%
Revvity, Inc.RVTY · Waltham, MA 17.79B 159.43 −2.48%
Repligen CorporationRGEN · Waltham, MA 11.39B 178.20 −0.04%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 9.26B 99.04 −0.23%
Pegasystems Inc.PEGA · Waltham, MA 5.62B 34.36 +0.03%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.46B 31.49 +1.38%
Crane NXT, Co.CXT · Waltham, MA 3.55B 61.62 +2.63%

The stocks whose daily moves over the past year went most closely with Akebia Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Dyne Therapeutics, Inc.DYN · Correlation 0.30 3.46B 18.54 +2.71%

What visitors to Akebia Therapeutics's page also look at.

Company Mkt cap Price Today
Ardelyx, Inc.ARDX 849.44M 3.2900 +8.58%
Kyntra Bio, Inc.KYNB 16.03M 3.9600 −8.12%
Karyopharm Therapeutics Inc.KPTI 1.65M 0.0729 −17.44%
Aldeyra Therapeutics, Inc.ALDX 39.06M 0.6474 +4.32%
Abeona Therapeutics Inc.ABEO 241.32M 4.2200 −0.71%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All AKBA news ›
Stock Titan·

Akebia Therapeutics: Nicholas Grund to resign Nov. 6

The commercial chief at Akebia Therapeutics (AKBA) plans to resign for personal reasons. Stock Titan Akebia Therapeutics: Nicholas Grund to resign Nov. 6 Nicholas Grund's consulting engagement is scheduled to continue through April 30,…

AKBA
MarketScreener·

Akebia Therapeutics, Inc. : Insider Transactions

Follow insider transactions on Akebia Therapeutics, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Akebia Therapeutics, Inc. Latest insider transactions for…

AKBAAZNKURA

From the 4Search news index, newest first.

In the news

18mentions in 30 days
17with it in the headline
Positivesentiment

Mentioned with

Akebia Therapeutics, Inc.11Akebia Therapeutics, Inc8Chart Akebia Therapeutics, Inc8Astrazeneca6Wells Fargo 21St Annual Healthcare Conference6Novo Nordisk5Mckesson4Novartis4

People in the coverage

Akebia14Michael Walen12Danessa Lincoln9Korro Bio9Kim Johansen8Sarita Garza7

Themes

Therapeutics10Healthcare9Financial6Quarter6Reports6Results6Second6Earnings5

Most coverage from

  1. marketscreener.com10
  2. marketbeat.com3
  3. stocktitan.net2
  4. defenseworld.net1
  5. kalkinemedia.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance